Literature DB >> 8608274

Bovine Creutzfeldt-Jakob disease?

S M Gore.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8608274      PMCID: PMC2350719          DOI: 10.1136/bmj.312.7034.791

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease.

Authors:  P Brown; M A Preece; R G Will
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

2.  Acquired immune deficiency syndrome predictions for England and Wales (1992-97): sensitivity analysis, information, decision.

Authors:  N E Day; S M Gore; D De Angelis
Journal:  J R Stat Soc Ser A Stat Soc       Date:  1995       Impact factor: 2.483

3.  Escape from collective denial: HIV transmission during surgery.

Authors:  A G Bird; S M Gore; A J Leigh-Brown; D C Carter
Journal:  BMJ       Date:  1991-08-10

4.  An investigation of risk factors for cases of bovine spongiform encephalopathy born after the introduction of the 'feed ban'.

Authors:  L J Hoinville; J W Wilesmith; M S Richards
Journal:  Vet Rec       Date:  1995-04-01       Impact factor: 2.695

  4 in total
  5 in total

1.  Recipients of blood or blood products "at vCJD risk".

Authors:  Sheila M Bird
Journal:  BMJ       Date:  2004-01-17

2.  Bovine spongiform encephalopathy. Study shows need for better communication between government and doctors.

Authors:  C Simpson; S Dealler; W Patterson
Journal:  BMJ       Date:  1996-11-02

3.  Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Scientists who inflame public anxieties must share responsibility for resulting panic.

Authors:  M Fitzpatrick
Journal:  BMJ       Date:  1996-04-20

4.  Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Risk to human population is remote.

Authors:  S Neilson
Journal:  BMJ       Date:  1996-04-20

5.  Study-design in pandemics: From surveillance and performance-evaluation to licensing and pharmacovigilance.

Authors:  Sheila M Bird
Journal:  Pharm Stat       Date:  2022-07       Impact factor: 1.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.